Abstract
The Toxic Oil Syndrome (TOS), which occurred in Spain in 1981, was caused by the ingestion of rapeseed oil denatured with 2% aniline, sold illegally as edible oil. The number of unaffected individuals exposed to the toxic oil is unknown, but more than 20,000 people suffered from the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguilera B (1989) Lesiones vasculares en el Síndrome Tóxico por aceite de colza. Doctoral Thesis, Madrid Universidad Autónoma 26–41.
Bell SA, Hobbs MV, Rubin RL (1992) Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J. Immunol. 148: 3369–3376.
Blasco R, Ruiz-Gutierrez V (1992) Effect of fatty acid anilides on immune responses of Swiss mice. Clin. Exp. Immunol. 89: 131–135.
De Andrés B, del Pozo V, Gallardo S, de Arruda-Chaves E, Cárdaba B, Martin-Orozco E, Posada M, Palomino P, Lahoz C (1995) Improved method for mRNA extraction from paraffin-embedded tissues. Biotechniques 18(1): 42–43.
Gallardo S, del Pozo V, Cárdaba B, de Andrés B, Martin-Orozco E, Fernandez JC, Tramón P, Posada M, Abaitua I, Palomino P, Lahoz C (1994) Immunological basis of toxic oil syndrome (TOS). Toxicology 93:289–299.
Gleichmann H, Gleichman E (1984) GVHD a model for the Spanish Toxic Oil Syndrome. Lancet, i: 1174–1175.
Goldman M, Druet P, Gleichmann E (1991) Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12(7): 223–227.
Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson D I (1988) Elevated levels of soluble IL-2 receptors in Multiple Sclerosis. New Eng. J. Med. 319:1019–1020.
Kammüller M E, Penninks A H, Seinen W (1984) Spanish Toxic Oil Syndrome is a chemically induced graft-versus-host-like epidemic. Lancet, i: 1174–1175.
Kammüller M E, Bloksma N, Seinen W (1988) Chemically induced autoimmune reactions and Spanish toxic oil Syndrome. Focus on hydantoins and related compounds. J. Toxicol. 26:157–174.
Kammüller ME., Bloksma N, Seinen W. (1989) Autoimmunity and toxicology. Immune dysregulation induced by drugs and chemicals. In: Kammüller M.E., Bloksma, N. and Seinen, W. (eds), Autoimmunity and toxicology. Immune dysregulation induced by drugs and chemicals. Elsevier, Amsterdam, pp 4–34.
Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM (1991) Functional subsets of allergen-reactive human CD4+ T cells. Immunol. Today 12(11): 392–395.
Kapsenberg ML, Jansen HM, Bos JD, Wierenga E A (1992) Role of type 1 and type 2 T helper cells in allergic diseases. Curr. Opin. Immunol. 4: 788–793.
Kaufman LD, Gruber BL, Gómez-Reino JJ, Miller F (1994) Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome. Arch. Dermatol 130: 41–47.
Kilbourne EM (1983) Clinical epidemiology of toxic oil syndrome. New. Engl. J. Med. 309: 1408–1414.
Kilbourne EM, Bernert JT, Posada M et al. (1988) Chemical correlates of the pathogenicity of oils related to the TOS epidemic in Spain. Am. J. Epidemiol. 127: 1210–1227.
Kilbourne EM, Posada M, Abaitua I, et al. (1991) Toxic Oil Syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. J. Am. Coll. Cardiol. 18: 711–717.
Lahoz C, Tricas L, Vela C, Lauzurica P, Gurbindo C, Garcia R (1983) Hyper IgE, eosinophilia and immunological hyperreactivity due to ingestion of adultered rapeseed oil (Toxic Oil Syndrome). Eur. J. Respir. Dis. 62: 415–418.
Lahoz C, Rose NR, Robinson CJG (1992) Immunology. In: Nadal, J and Tarkowski, S (Eds), “Toxic Oil Syndrome: current Knowledge and future perspectives”. WHO Regional Publications, European series, no 42, pp. 143–152.
Lassalle P, Sergant M, Delneste Y, et al. (1991) Levels of soluble IL-2 receptor in plasma from asthmatics. Correlation blood eosinophilia, lung functions, and corticosteroid therapy. Clin. exp. Immunol. 87: 266–271.
Martínez Tello FJ, Téllez Y (1992) Pathology In: Nadal, J. and Tarkowski, S. (Eds), “Toxic Oil Syndrome: current Knowledge and future perspectives”. WHO Regional Publications, European series, no 42, pp. 39–65.
Manoussakis MN, Papadoppulos GK, Drosos AA, Motsopoulos HM (1989) Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune disease. Clin. Immunol. Immunopathol. 50:321–32.
Mayeno AN, Belongia EA, Fengling Lundu SK, Gleich GJ (1992) 3-(Phenyl-amino) alanine, a novel aniline-derived aminoacid associated with the Eosinophilia-Myalgia Syndrome: a link to the Toxic Oil Syndrome?. Mayo Clin. Proc. 67:1134–1139.
McKinley KL, Harati Y, Schneider LW (1993) Chronic immune activation in the eosinophilia-myalgia syndrome. Muscle & Nerve 16: 947–951.
Romagnani S. (1991) Human Th1 and Th2 subsets: doubt no more. Immunol. Today. 12(8): 256–257.
Scott P, Kaufmann HE (1991) The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today. 12(10): 346–348.
Silverman ED, Laxer R, Nelson DL, Rubin L A (1991) Soluble interleukin 2 receptor in juvenile rheumatoid arthritis. J. Rheumatol. 18: 1398–1402.
Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okomura K, Hirose S (1989) Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Annals of Rheumatic Diseases 48: 803–809.
Tricas, L. (1984) “Immunological hyperreactivity in the acute phase of TOS” Doctoral Thesis, University of Zaragoza.
WHO (1991) “Toxic oil syndrome and eosinophilia-myalgia syndrome. Pursuing parallels in pathogenesis”. Report on a WHO meeting, Washington, DC., WHO Regional Office for Europe, Copenhagen, 22 pp.
WHO (1992) “Toxic oil syndrome and eosinophilia-myalgia syndrome. Clinical aspects”. Report on a workshop. Stony Brook, New York. WHO Regional Office for Europe, Copenhagen, 19 pp.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lahoz, C. et al. (1997). Immunological Aspects of the Toxic Oil Syndrome. In: Seiler, J.P., Vilanova, E. (eds) Applied Toxicology: Approaches Through Basic Science. Archives of Toxicology, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60682-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-60682-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64505-1
Online ISBN: 978-3-642-60682-3
eBook Packages: Springer Book Archive